SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-024539
Filing Date
2019-05-08
Accepted
2019-05-08 17:03:27
Documents
59
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tv519765_10q.htm 10-Q 434516
2 EXHIBIT 31.1 tv519765_ex31-1.htm EX-31.1 11358
3 EXHIBIT 32.1 tv519765_ex32-1.htm EX-32.1 4688
4 GRAPHIC tv519765_img01.jpg GRAPHIC 79156
  Complete submission text file 0001144204-19-024539.txt   6579637

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT syn-20190331.xml EX-101.INS 2130854
6 XBRL TAXONOMY EXTENSION SCHEMA syn-20190331.xsd EX-101.SCH 40568
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20190331_cal.xml EX-101.CAL 38927
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20190331_def.xml EX-101.DEF 271173
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20190331_lab.xml EX-101.LAB 310933
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20190331_pre.xml EX-101.PRE 313424
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 19807536
SIC: 2834 Pharmaceutical Preparations